About Susmed
Susmed is a company based in Tokyo (Japan) founded in 2015. Susmed has raised $880 thousand across 1 funding round. Susmed operates in a competitive market with competitors including Oura, Muse, Jawbone, Biotricity and Sunrise, among others.
- Headquarter Tokyo, Japan
- Stage Public
- SectorsHealthcareTechnology
- Website category Health · Biotechnology and Pharmaceuticals
- Website susmed.co.jp
- Legal Name Susmed,Inc.
- Annual Revenue$3.06 M (USD)7.39as on Jun 30, 2026
- Net Profit-$2.36 M (USD)-28.25as on Jun 30, 2026
- EBITDA-$1.97 M (USD)-9.77as on Jun 30, 2026
- Total Equity Funding$880K (USD)
in 1 rounds
- Latest Funding Round$880K (USD), Seed
Feb 2017
Funding Insights of Susmed
Susmed has successfully raised a total of $880K through 1 strategic funding round. The most recent funding activity was a Seed round of $880 thousand completed in February 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $880,000
- Total Rounds 1
- Last Round Seed — $880,000
- First Round $880,000
(Feb 2017)
All 1 funding rounds of Susmed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2017 | $880,000 | Seed | – | – | – |
People of Susmed
1 people are tracked at Susmed (1 in leadership).
| Name | Role | Group |
|---|---|---|
Taro Ueno | CEO | Leadership |
Complete people profiles for Susmed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Susmed
Susmed is a publicly listed company on the TSE with ticker symbol 4263 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Dec 2021
- Listed onTSE: 4263
- Listed entitySUSMED,Inc.
- Exchange sectorHealth technology
- ISINJP3319150003
- Share price395.00 JPY (-0.75% on the day) · 2026-10-09
- Market capitalisation6,713,503,487.00 JPY
- EPS (diluted, trailing year)-22.72 JPY
- Volume (last session)71,100
Financials of Susmed
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2026 | 497.2M JPY | -382.7M JPY | -320.0M JPY |
| 2025 | 463.0M JPY | -298.4M JPY | -291.5M JPY |
| 2024 | 342.6M JPY | -357.4M JPY | -359.0M JPY |
| 2023 | 530.6M JPY | -50.8M JPY | -42.8M JPY |
| 2022 | 316.9M JPY | -233.5M JPY | -227.1M JPY |
Detailed financial statements for Susmed
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Susmed
3 dated milestones of Susmed across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Susmed is founded.
- Funding First funding round of $880K.
- IPO Lists on the stock exchange (IPO).
Competitors of Susmed
Susmed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oura, Muse, Jawbone, Biotricity and Sunrise, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ouraring.com | 2013 | Oulu, Finland | $1.32B | – | Health-tracking smart rings and biosensors are developed for biometric monitoring. | |
| choosemuse.com | 2007 | Toronto, Canada | $58.56M | 49 | EEG-powered headbands for meditation and sleep biofeedback are developed. | |
| jawbone.com | 1997 | San Francisco, United States | $877.03M | – | Provider of wearable devices for activity and sleep tracking | |
| biotricity.com | 2014 | San Francisco, United States | – | 55 | Developer of medical remote monitoring solutions that help prevent and manage chronic diseases | |
| hellosunrise.com | 2013 | Namur, Belgium | $52.85M | 12 | Sunrise is focused on sleep apnea diagnostic solutions. | |
| sleepscore.com | 2016 | San Diego, United States | $1.85M | 34 | Sleep quality is monitored via bedside devices and mobile apps. | |
| novasom.com | 1992 | Glen Burnie, United States | $55M | 167 | Home sleep testing for obstructive sleep apnea is offered. | |
| nyxoah.com | 2009 | Mont Saint Guibert, Belgium | $88.73M | 11 | Provider of a neurostimulation device for obstructive sleep apnea treatments | |
| dreem.com | 2014 | Paris, France | $44M | – | Sleep quality is monitored via Dreem's wearable EEG device. |
Detailed competitors of Susmed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Susmed
The website of Susmed (susmed.co.jp) receives about 3.1K visits a month and ranks #4,278,053 among all websites worldwide, #5,271 in Biotechnology and Pharmaceuticals.
- Monthly visits3.1K
▼ 15.2% vs previous month
- Unique visitors1.7K
per month
- Global rank#4,278,053
among all websites
- Category rank#5,271
Health · Biotechnology and Pharmaceuticals
- Bounce rate65%
- Pages per visit2.2
- Average visit36 sec
- DevicesDesktop 37% · Mobile 63%
Websites whose visitors overlap most with Susmed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mixonline.jp | 100% | – | #252,634 | View details | |
jssr.jp | jssr.jp | 60% | – | #1,136,679 | – |
jact.jp | jact.jp | 31% | – | #3,601,963 | – |
Latest news on Susmed
Complete news archive for Susmed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Susmed
10 companies that operate in the same segment as Susmed (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 713.57 M | – | – | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 233 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | – | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 508.73 M | – | – | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, France | USD 863.12 M | – | – | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | – | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | – | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Susmed
Susmed was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Susmed is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Taro Ueno is the current CEO of Susmed.
Susmed is a funded company, having raised a total of $880K across 1 funding round to date. The company's 1st funding round was a Seed of $880K, raised on Feb 2017.
Annual revenue of Susmed is $3.06M as on Jun 30, 2026.
Susmed was founded in 2015 in Tokyo, Japan, within the health technology sector. Operations center on the iOS app The Yawn, where user inputs are analyzed algorithmically to generate recommendations for managing insomnia. Clinical trials have been conducted since September 2016 in partnership with Harumi Hospital, affiliated with the National Institute for Neurological Research, and Yumikai Kikami Hospital, a social medical corporation.
Yes, Susmed is publicly traded on TSE under the ticker symbol 4263.